Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 4Unknown 2Terminated 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Other 1

Conditions

Prostatic Neoplasms 2Sexual Dysfunction, Physiological 1

Interventions

Radiotherapy 106Cyclophosphamide 97Cisplatin 75Carboplatin 66Fluorouracil 64Etoposide 61Doxorubicin 60Chemotherapy, Adjuvant 60Vincristine 56Peripheral Blood Stem Cell Transplantation 48Filgrastim 47Paclitaxel 46Gemcitabine 44Cytarabine 41Neoadjuvant Therapy 40Leucovorin 40Docetaxel 35Melphalan 31Oxaliplatin 29Methotrexate 29Ifosfamide 25Gene Expression Profiling 25Amplified Fragment Length Polymorphism Analysis 24Immunohistochemistry 23Dexamethasone 22Irinotecan 21aldesleukin 20Prednisolone 20Interferon-alpha 20Tamoxifen 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × NIH × High-Intensity Focused Ultrasound Ablation × Clear all
NCT00987675 2013-08-26

High-Intensity Focused Ultrasound Ablation in Treating Patients With Progressive Prostate Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
26 enrolled
Genitourinary

Prostatic Neoplasms

NCT00988130 2013-08-26

High-Intensity Focused Ultrasound Focal Ablation in Treating Patients With Progressive Prostate Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
26 enrolled
GenitourinaryOther

Prostatic Neoplasms, Sexual Dysfunction, Physiological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡